Assessment of ARIA Sufficiency: Siliq (brodalumab)

    Basic Details
    Approval Date
    Wednesday, February 15, 2017
    Health Outcome(s)
    adverse pregnancy and fetal outcomes
    fatal major adverse cardiac events
    hospitalized neutropenia
    malignancy
    myocardial infarction and stroke
    opportunistic infections
    outpatient neutropenia
    serious infection
    suicidal ideation and behavior